Lactose intolerance- 65% chance you have it
People of European descent can drink milk and the rest of the globe has lactose intolerance. There are however substances in milk that none of us can tolerate.
Milos Pokimica
Written By: Milos Pokimica
Medically Reviewed by: Dr. Xiùying Wáng, M.D.
Updated May 7, 2023People of European descent can drink milk and the rest of the globe has lactose intolerance. Black Africans are 98 percent lactose intolerant and numbers for lactose intolerance in Asia are similar (Ugidos-Rodríguez et al.)[1].
Scientific research confirmed in different ancient European genome studies that the hunter-gatherers in Europe could not digest lactose in milk 8000 years ago. The first Europeans who domesticated wild animals were also unable to consume milk. The settlers who came from the Near East about 7800 years ago also had lactose intolerance. The Yamnaya pastoralists who came to Europe from the eastern steppes around 4800 years ago also had lactose intolerance.
It was not until about 2300 BC about 4300 years ago, in the early Bronze Age, that lactose tolerance swept through Europe (Gamba et al.)[2]. When we look at today’s world most of the population still can’t digest milk. If lactose-intolerant individuals consume lactose-containing products, they may experience bloating, nausea, abdominal pain, flatulence, and diarrhea.
Lactose is split down into a regular usable sugar by a specific enzyme called lactase created by cells in the wall lining of the small intestine (Storhaug et al.)[3]. Production of lactase is turned off in mammals in adulthood because mammals breastfeed only in the first periods after birth. Later in life in average conditions, it is not necessary to have this enzyme because no mammal will ever breastfeed again, except humans. Grown mammalian species do not breastfeed, and the organism is adapted to turn enzymes off to save energy. By domesticating wild animals and milking them, early farmers changed the condition of their habitat, and in time organisms adapted.
Today only descendants of European farmers can still digest milk. Black Africans cannot. Asians cannot. The statistic for lactose intolerance is like this. Approximately 65 percent of the entire human population has a reduced ability to digest lactose after infancy. In comparison, 5 percent of people of Northern European descent are lactose intolerant.
There are, however, a lot of substances in milk that we cannot tolerate. Even if we are from dairy queen countries we still can’t cope very well with things like cholesterol, a form of Lacto morphine called casomorphin, and estradiol (dairy consumption accounts for 60 to 80 percent of all estrogen consumed in the typical American diet). Opiates from the mother’s milk produce a sedative effect on the infant. That sedative effect is responsible for a good measure of the mother-infant bond. Milk has a drug-like effect on the baby (or other mammalian cubs), and it guarantees that the baby will bond with the mom and proceed to the nurse and get the nutrients. It is an evolutionarily beneficial adaptation. Similar to heroin or codeine, casomorphins slow intestinal movements and have an antidiarrheal effect. The opiate effect is the reason why cheese can be constipating just as opiate painkillers are.
Lactase is an enzyme that allows the organism to digest milk sugar, and that sugar is lactose. Danes are only 2% lactose intolerant.
All mammals after rejection from sucking are lactase deficient. They do not have contact with the milk later in life. The reactions of any organism that does not need to use the sugar lactose in adulthood are to deactivate the enzyme lactase so that the enzyme lactase is deactivated at the level of the genes. Except for the European farmers, which forced their bodies for thousands of years to consume it.
Thus, Danes today are only 2% non-tolerant, Finland 18%, Indians 50%, Israeli Jews 58%, African American 70%, Ashkenazi Jews 78%, Arabs 78%, Taiwanese 85%, Greek Cypriots 85%, Japanese 85%, Thailand 90%, Filipino 90%, Black African over 90% (Storhaug et al.)[3]. WHO has put that number up, saying that it is around 95% to 100%, for Indians 90 to 100, for Asians 90 to 95, for Mediterranean 60 to 75 and North American 10 to 15 and Europe 5 to 10 percent.
The real problem is that even if we are lactose tolerant lactose is metabolized in an unnatural way and is not meant to be consumed for an extended period of time. We have the enzyme lactase that breaks sugar lactose on dextrose and galactose. Half is glucose and the other half is galactose.
However, galactose cannot be used until it is digested in glucose. Cells only use glucose as fuel. There is an enzyme called beta-galactosidase that changes galactose into the glucose that we need. However, since no animal needs this enzyme after rejection, this enzyme is deactivated forever. Everyone, every human on the planet Earth if it is a grown individual has galactosidase deficiency. All of you who are reading this now and I have a deficiency of beta-galactosidase. This means that if you consume sugar from milk meaning lactose if you are lactose tolerant you can use it, you have lactase. Lactase metabolizes lactose and you will get glucose and besides it galactose. Glucose will be used normally. And with galactose, what are we going to do? We cannot use it so where does galactose go?
Some of it gets ejected outside through the skin. Some end up in the eyes and are stored in the cornea. Elderly cataracts come from galactose. Adults who consume large amounts of milk, and have high lactase activity, often suffer from galactose accumulation of galactitol in the eye lobe and have a high likelihood of elderly cataracts (Arola et al.)[4].
Not only that but it is also stored in the body in other places as well. Women are accumulating around the ovaries, and it is associated with cancer of the ovaries and infertility. One in four couples goes to infertility treatments in European countries. In African countries, where they do not use milk, they have no problems with infertility. It is unknown as a disease. In Daniel W. Cramer Harvard Medical School study (Mustafa et al.)[5] a link between the consumption of galactose and the increased risk of ovarian cancer was observed. Lactose-intolerant women are likely to consume less lactose. They concluded that: “This finding suggests that decreased lactose intake early in life may reduce ovarian cancer risk although further studies are needed to confirm this finding.” For Thai women, for example, who do not consume milk, there is no infertility at the level of statistical significance. In Thailand where 98% of adults are lactose intolerant, the average fertility among women aged 35-39 years was only 26% lower than the maximum rate for ages 25-29 years. In Australia and the UK, where lactose intolerance affects only 5% of adult people the fertility rates for 35-39 years old are full 82% below the maximum rate for 25-29 years.
Besides the risks of milk consumption in lactose-tolerant individuals can drink milk, what will happen when an individual that is not tolerant of lactose drinks milk? Sugar from milk will be undigested. It will cause lactose to be broken down by bacteria in the intestines. Bacteria will start to multiply, this increases osmotic pressure, fluid flows into the intestines, and the individual gets diarrhea.
After World War 2, the U.S. had a big stockpile of powdered milk that they had to dispose of somehow. Instead, they decided that because there is a “protein gap” they send that powdered milk to Africa as humanitarian aid. Many already malnourished children and babies got diarrhea from it. African countries that got milk powder sent as humanitarian aid experienced an increase in mortality, especially in small children who were already at the level of severe malnutrition.
References:
Passages selected from a book: Pokimica, Milos. Go Vegan? Review of Science Part 1. Kindle ed., Amazon, 2018.
- Ugidos-Rodríguez, Santiago, et al. “Lactose Malabsorption and Intolerance: A Review.” Food & Function, vol. 9, no. 8, Royal Society of Chemistry, Aug. 2018, pp. 4056–68. https://doi.org/10.1039/c8fo00555a.
- Gamba, Cristina et al. “Genome flux and stasis in a five millennium transect of European prehistory.” Nature communications vol. 5 5257. 21 Oct. 2014, doi:10.1038/ncomms6257
- Storhaug, Christian Løvold et al. “Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis.” The lancet. Gastroenterology & hepatology vol. 2,10 (2017): 738-746. doi:10.1016/S2468-1253(17)30154-1
- Arola, H, and A Tamm. “Metabolism of lactose in the human body.” Scandinavian journal of gastroenterology. Supplement vol. 202 (1994): 21-5. doi:10.3109/00365529409091741
- Mustafa, Osama M., and Yassine J. Daoud. “Is Dietary Milk Intake Associated With Cataract Extraction History in Older Adults? An Analysis From the US Population.” Journal of Ophthalmology, vol. 2020, Hindawi Publishing Corporation, Feb. 2020, pp. 1–7. https://doi.org/10.1155/2020/2562875.
- Merritt, Melissa A et al. “Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.” International journal of cancer vol. 132,5 (2013): 1114-24. doi:10.1002/ijc.27701
Do you have any questions about nutrition and health?
I would love to hear from you and answer them in my next post. I appreciate your input and opinion and I look forward to hearing from you soon. I also invite you to follow us on Facebook, Instagram, and Pinterest for more diet, nutrition, and health content. You can leave a comment there and connect with other health enthusiasts, share your tips and experiences, and get support and encouragement from our team and community.
I hope that this post was informative and enjoyable for you and that you are prepared to apply the insights you learned. If you found this post helpful, please share it with your friends and family who might also benefit from it. You never know who might need some guidance and support on their health journey.
– You Might Also Like –

Learn About Nutrition
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Medical Disclaimer
GoVeganWay.com brings you reviews of the latest nutrition and health-related research. The information provided represents the personal opinion of the author and is not intended nor implied to be a substitute for professional medical advice, diagnosis, or treatment. The information provided is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH GoVeganWay.com
NEVER APPLY ANY LIFESTYLE CHANGES OR ANY CHANGES AT ALL AS A CONSEQUENCE OF SOMETHING YOU HAVE READ IN GoVeganWay.com BEFORE CONSULTING LICENCED MEDICAL PRACTITIONER.
In the event of a medical emergency, call a doctor or 911 immediately. GoVeganWay.com does not recommend or endorse any specific groups, organizations, tests, physicians, products, procedures, opinions, or other information that may be mentioned inside.
Editor Picks –
Milos Pokimica is a health and nutrition writer and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Latest Articles –
Top Health News — ScienceDaily
- Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdoseon June 3, 2026
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and […]
- This new diabetes pill burns fat without the downsides of Ozempicon June 3, 2026
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated.
- Scientists reverse anxiety by fixing a tiny brain circuiton June 3, 2026
A newly identified group of amygdala neurons appears to play a central role in anxiety and social behavior. Restoring normal activity in this tiny brain circuit reversed anxiety and social deficits in mice, revealing a promising new target for future treatments.
- Scientists discovered something surprising about french fries and diabeteson June 3, 2026
French fries may be the real potato problem. A large study tracking more than 205,000 people for nearly 40 years found that eating three servings of fries per week was linked to a 20% higher risk of developing type 2 diabetes, while baked, boiled, or mashed potatoes showed no significant increase in risk. The research also found that swapping potatoes for whole grains lowered diabetes risk, while replacing them with white rice had the opposite effect.
- Brain scans reveal two distinct types of autismon June 3, 2026
Scientists have uncovered evidence that autism may include at least two biologically distinct subtypes, each marked by a different pattern of brain communication. By combining brain scans from nearly 1,000 people with autism with insights from 20 genetically engineered mouse models, researchers identified a “hyperconnectivity” subtype, where brain regions communicate more than usual, and a “hypoconnectivity” subtype, where communication is reduced.
- A single protein may be holding back CAR T cancer therapyon June 2, 2026
A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these engineered immune cells to become exhausted and lose their cancer-fighting power over time. When NFIL3 was disabled, the cells remained stronger for longer and controlled tumors more effectively in animal models.
- Scientists discover gut bacteria that may help protect against autism and ADHDon June 2, 2026
A major study suggests that some of the groundwork for brain development may be shaped before birth through a surprising partnership between a baby’s genes and gut microbes. Researchers found that epigenetic changes present at birth can influence how the gut microbiome develops during the first year of life, and certain combinations were linked to early signs of autism and ADHD by age three.
PubMed, #vegan-diet –
- Editorial: Recent insights in vegetarian nutritionon June 1, 2026
No abstract
- Pet food choices in transition: how owner demographics and diets influence pet food selection and the acceptance of alternative protein sources in pet feedingon June 1, 2026
Given the increasing interest in alternative protein sources and growing ethical awareness in nutrition, this large-scale survey (n = 8,823) investigated the feeding practices of dog and cat owners in mainly German-speaking countries. The aim was to assess preferences, feeding habits, and the acceptance of novel protein sources such as plant- and insect-based pet foods. The results showed that conventional meat-based diets remained predominant (i.e., 53.05% daily feeding of meat-based dry […]
- Environmental Footprint of a Low-Fat Vegan Diet in People With Type 1 Diabetes: A Secondary Analysis of a Randomized Clinical Trialon May 29, 2026
A 12-wk randomized clinical trial found that adults with type 1 diabetes on a low-fat, vegan diet (n = 29) showed greater improvements in insulin sensitivity compared with a portion-controlled diet (n = 29). This secondary analysis calculates the greenhouse gas emissions (GHGEs) and cumulative energy demand (CED) of both diets by linking 3-d dietary records to external data sources. A repeated-measures analysis of variance was performed unadjusted and adjusted for change in energy intake. […]
- Protein intake and preservation of function in old age : Current evidence and present research gapson May 28, 2026
In the past, large observational cohort studies suggested that a higher protein intake might slow the age-associated loss of muscle mass and muscle strength. This observation led to the conclusion that a higher protein intake may contribute to a preservation of function and to the prevention of sarcopenia. Therefore, the German Nutrition Society increased their recommendation for daily protein intake in adults aged ≥ 65 years from 0.8 to 1.0 g/kg body weight (estimated value); however, […]
- Flexitarian dietary patterns and neuropsychiatric multimorbidity among the oldest-old in Chinaon May 27, 2026
CONCLUSION: In this nationally representative sample of older Chinese adults, flexitarian dietary patterns were not associated with better neuropsychiatric health and were instead linked to higher odds of depression, cognitive impairment, and their co-occurrence. These results suggest that plant-forward diets in the oldest-old should place greater emphasis on overall dietary quality and nutrient adequacy.
Random Posts –
Featured Posts –
Latest from PubMed, #plant-based diet –
- Effect of steam-pelleting or extrusion on nutrient digestibility of ground barley or faba bean in growing pigsby U S Ruiz on June 3, 2026
Plant-based feedstuffs may have limitations in nutrient digestibility and nutritional value for pigs that might be ameliorated using heat processing technologies. Thus, the main objective was to evaluate the effect of steam-pelleting or extrusion on digestibility of starch, crude protein (CP), amino acids (AA), and gross energy (GE) of the two contrasting ingredients barley and faba bean in growing pigs. Barley and faba bean ingredients were ground (2.8-mm hammer mill screen), and a portion […]
- Dose-dependent effects of dietary quercetin supplementation on growth performance, nutrient digestibility, meat composition, bone mineralization, and profitability in broilersby Md Abu Saied on June 2, 2026
Objectives: This study aimed to determine the optimal dose of quercetin (plant origin) on growth performance, nutrient digestibility, meat composition, shank mineralization, and production costs in broilers. Materials and Methods: A total of 180 day-old, mixed-sex Ross 308 chicks were randomly assigned to four dietary groups, with five replicates of nine birds per group. The corn-soy-based basal diet provided 2998 kcal metabolizable energy (ME)/kg and 22.94% crude protein (CP) in the starter…
- Quantitative comparison of food-based dietary guidelines: alignment with the Slovenian nutrition guidelines 2025 and Slovenian intakeby Samo Kreft on June 2, 2026
CONCLUSIONS: The SNG2025 are well aligned with contemporary international and national recommendations and align with widely accepted quantitative ranges for all major food groups. Differences between guidelines reflect cultural framing and quantification rather than conflicting nutritional principles. The SNG2025 demonstrate that contemporary dietary guidelines can integrate quantitative guidance, a plant-forward approach, and sustainability considerations while remaining aligned with…
- Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023by GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators on June 2, 2026
BACKGROUND: Enteric infectious diseases claim more than 1 million lives annually and are among the top ten causes of death in children younger than 5 years. Remarkable global investment has been dedicated to enteric infectious disease prevention and control; however, the shifting global health landscape is testing the continuance of progress. To evaluate the current status and guide future interventions, we present the latest epidemiological estimates of enteric infectious diseases from the…
- Plant-Based Eating: Exploring at Home vs Dining Out Behaviours Across Consumer Segmentsby Carla Riverola on June 2, 2026
A global shift toward predominantly meat-free diets is essential to achieve more sustainable food systems, yet the transition remains far from complete. This paper investigates the systemic and behavioural dynamics shaping the adoption of plant-based eating of veg*ns, meat reducers, and omnivores in different dining settings. We analyse data from 3,014 Australian participants recruited primarily through a plant-based living magazine to uncover the drivers and barriers for choosing plant-based…
- Adherence to the EAT-Lancet diet and neuropsychiatric disorders: a systematic review and meta-analysisby Yuhao Wang on June 1, 2026
Neuropsychiatric disorders (NPDs) are a leading cause of disability worldwide. The predominantly plant-based EAT-Lancet diet has been proposed to confer neuropsychiatric benefits, yet evidence remains limited. This study synthesized associations between adherence to the EAT-Lancet diet and neuropsychiatric outcomes. We searched PubMed, Web of Science, Embase, Scopus, and ProQuest Dissertations and Theses Global through September 4, 2025. Observational studies reporting associations between…












